Management of Asthma Exacerbation in a 3-Year-Old
For a 3-year-old with an asthma exacerbation, immediately administer salbutamol (albuterol) 5 mg via nebulizer or 2-10 puffs via metered-dose inhaler with spacer, plus oral prednisolone 1-2 mg/kg (maximum 40 mg), and provide high-flow oxygen if the child has severe symptoms. 1, 2
Initial Assessment
Rapidly evaluate for features indicating severity:
Moderate exacerbation indicators:
Life-threatening features requiring immediate intensive intervention:
- Poor respiratory effort or silent chest 1
- Cyanosis, fatigue, or exhaustion 1
- Agitation or reduced level of consciousness 1
Immediate Treatment Protocol
First-Line Bronchodilator Therapy
Deliver salbutamol using either method (both are equally effective):
- Nebulizer route: 2.5 mg (half dose for very young children under 2 years) via oxygen-driven nebulizer 1, 2
- MDI with spacer: 2-10 puffs (actuate one puff at a time, allow child to breathe it in, repeat) using a large volume spacer with face mask 1, 3
The MDI with spacer approach offers significant advantages: shorter treatment time (66 vs 103 minutes), less vomiting (9% vs 20%), and smaller heart rate increases compared to nebulizers 4. Multiple studies confirm equivalent efficacy between these delivery methods 3, 4, 5.
Corticosteroid Administration
Give oral prednisolone 1-2 mg/kg (maximum 40 mg) immediately 1, 2, 6. This can be repeated daily for up to 5 days with no tapering required 7, 6. The FDA-approved dosing for pediatric asthma exacerbations is 1-2 mg/kg/day, continued until symptoms resolve or peak flow reaches 80% of baseline, typically requiring 3-10 days 6.
Oxygen Therapy
Administer high-flow oxygen via face mask to maintain oxygen saturation >92% in children with moderate to severe symptoms 1, 2.
Reassessment and Escalation
Evaluate response after 15-30 minutes 1, 2:
If Improving:
- Continue bronchodilators every 4 hours 1, 2
- Continue oral prednisolone daily 1
- Monitor oxygen saturation 1
If NOT Improving:
- Increase bronchodilator frequency to every 30 minutes 1
- Add ipratropium bromide 100 mcg nebulized every 6 hours 1, 8. Adding ipratropium to salbutamol produces significantly greater improvement in lung function parameters than salbutamol alone 8.
- Consider intravenous hydrocortisone if unable to tolerate oral medication 1
Life-Threatening Features Present:
- Arrange immediate transfer to intensive care unit 1
- Consider intravenous aminophylline 5 mg/kg over 20 minutes (omit loading dose if already on oral theophyllines) 1
- Prepare for possible intubation 1
Critical Delivery Device Considerations for Age 3
Most 3-year-olds cannot properly coordinate an unmodified MDI 1, 7. A large volume spacer device with face mask is essential at this age 1, 7. The spacer enhances lung deposition and reduces systemic absorption 1, 9. Some children this age may manage powder inhalers (Turbohaler or Diskhaler), but this requires individual assessment 1.
Common Pitfalls to Avoid
- Do not rely on nebulizers exclusively - they are overused, expensive, time-consuming, and can often be replaced by MDI with spacer 1
- Do not delay corticosteroids - give prednisolone immediately, not after bronchodilator failure 1, 2
- Do not undertaper steroids after short courses - abrupt cessation after 3-10 days does not increase relapse risk 6
- Do not use aminophylline at home - this is reserved for hospital management of severe cases 1
Hospital Admission Criteria
Admit if any of the following occur 1:
- Failure to respond to initial bronchodilators or early deterioration 1
- Parents unable to give appropriate treatment at home 1
- Severe breathlessness with increasing tiredness 1
- Persistent symptoms after initial emergency treatment 1
Discharge Planning
Before discharge, ensure 1, 7:
- Child has been on discharge medications for 24 hours 1
- Inhaler technique verified and documented 1, 7
- Parents understand when to use "reliever" vs "preventer" medications 2
- Written action plan provided 7
- Follow-up arranged within 1 week 1, 2
- Prescription includes oral prednisolone to complete course and inhaled corticosteroids for ongoing control 1